MIAMI, FL – January 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, in an effort to provide support and resources for those concerned about the risks associated with the emerging threat posed by the spread of Wuhan Coronavirus (2019-nCoV), is pleased to provide critical educational and informational support services at this important stage in the progression of the disease.
What to Know. According to the World Health Organization (“WHO”), Coronaviruses (CoV) are “a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).”
On December 31, 2019, the WHO became aware of new strain – a “novel coronavirus (nCoV)” – not previously identified in humans that first appeared in the form of pneumonia in Wuhan City, Hubei Province of China. It appears as though this marks the emergence of a new infectious disease borne of a non-human-to-human virus in this region that mutated into a state allowing for human-to-human infectious transmission.
This disease has spread rapidly. Many questions still remain, including whether or not the disease is fully contagious in the pre-symptomatic incubation period. Chinese authorities and authorities in many countries are already taking rapid action to slow the spread of the disease, and biomedical facilities around the world are working hard to create a viable vaccine, with some early-stage candidate compositions already beginning animal testing.
Worldwide there are now more than 6,000 cases and 132 deaths, according to the European Centre for Disease Prevention and Control. There have been no reported deaths outside of China and all deaths have been in patients who were elderly or otherwise unwell. In the U.S., the CDC is reporting five confirmed cases from these states: Washington, Illinois, California, and Arizona, all of whom had recently visited Wuhan. According to the CDC, there is no evidence that 2019-nCoV has spread from human to human in the US, nor is there evidence that imported Chinese goods are affected. The mortality rate for those infected by 2019-nCoV is not yet fully understood but appears to be relatively low in the scale of prior serious infectious disease epidemics, with many patients recovering over a period of days back to full health.
What to Do. The WHO has a list of suggested guidelines for behavioral prevention of infection with Wuhan Coronavirus:
According to WebMD, symptoms include fever, coughing, and shortness of breath. They may appear 2 to 14 days after you’re exposed to the virus. The flu and its symptoms are common and it is recommended to be treated with Tamiflu® and more recently Relenza Diskhaler®. The Coronavirus is very similar to the flu and has most of the same symptoms aside from a history of travel exposure. Pamela Roberts, PharmD, Director of Pharmacy stated “Treatment would be similar for both viruses. Symptomatic care would consist of lots of fluids, rest, and OTC pain relievers as needed.”
“It is important to stay calm and follow common flu/disease prevention protocols. Wash hands thoroughly, avoid direct contact with anyone showing flu-like symptoms, and seek early diagnosis and treatment when symptoms present themselves,” said S. Parikh Mars, CEO.
For More Help. If you or someone you know has further questions or concerns about the risks posed by Wuhan Coronavirus, including how to prevent infection or how to respond to potential associated symptoms, please contact PharmCo, and a team member with expertise will be happy to assist you.
Our Toll-Free Number is 831-901-9111, or email us at Info@PharmcoRx.com
The CDC has provided the following link for current developments regarding 2019-nCoV: https://www.cdc.gov/coronavirus/index.html.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
Tweets by ProgressCareUS
Tweets by PharmCoRx
Five Star RX
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Public Relations Contact:
Caitlin Franscell, CMW Media